UK markets open in 5 hours 17 minutes

Bone Biologics Corporation (BBLG)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2727+0.0002 (+0.07%)
At close: 04:00PM EST
0.2800 +0.01 (+2.68%)
After hours: 04:28PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.2725
Open0.2889
Bid0.2655 x 40700
Ask0.2800 x 1100
Day's range0.2610 - 0.2889
52-week range0.2500 - 6.7800
Volume37,601
Avg. volume216,669
Market cap4.173M
Beta (5Y monthly)0.08
PE ratio (TTM)N/A
EPS (TTM)-0.1810
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.88
  • Business Wire

    Bone Biologics CEO Issues Letter to Stockholders

    BURLINGTON, Mass., October 25, 2022--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today issued the following letter to stockholders from its President and Chief Executive Officer, Jeffrey Frelick.

  • Business Wire

    Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

    BURLINGTON, Mass., October 12, 2022--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced underwritten public offering of units of securities for total gross proceeds of $5,100,000, before deducting underwriting discounts and commissions and other estimated offering expenses. The Company plans to use the net proceeds to fund its planned clinical trials, maintain and extend its patent por

  • Business Wire

    CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering

    BURLINGTON, Mass., October 07, 2022--Reissuing release to remove "million" after "$5,100,000" in the headline and first sentence of the text.